• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短篇通讯:一名长期大量吸食大麻的孕妇体内 11-去甲-9-羧基-Δ(9)-四氢大麻醇的尿排泄。

Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use.

机构信息

Department of Clinical Pharmacology, St. Olav University Hospital, N-7006 Trondheim, Norway.

出版信息

J Anal Toxicol. 2009 Nov-Dec;33(9):610-4. doi: 10.1093/jat/33.9.610.

DOI:10.1093/jat/33.9.610
PMID:20040136
Abstract

Differentiating new intake of drugs-of-abuse from residual drug excretion may be difficult, especially following chronic drug usage and for drugs with long elimination half-lives such as cannabis. In the present case, cannabis was found in the urine of a young pregnant woman following heavy and chronic cannabis use. She was warned that if she continued using cannabis while pregnant she would be forced to be hospitalized. She was subjected to serial urine testing with 2-7-day intervals. Urinary 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THCCOOH) concentrations, measured by liquid chromatography-mass spectrometry, declined from 348 to 3.9 ng/mL over a surprisingly long period of 12 weeks (84 days). Several algorithms for detecting new drug intake were applied during this time course; most indicated that the woman continued to smoke cannabis following the first urine test. The woman denied any use after the first specimen collection. In retrospect, her THCCOOH excretion profile supports her story. Algorithms for detecting new drug intake have been validated for occasional cannabis users only. We advise caution when interpreting urine test results from heavy, chronic cannabis users, especially when serious consequences are involved.

摘要

区分新摄入的毒品与残留的药物排泄可能很困难,特别是在长期吸毒和药物消除半衰期较长的情况下,如大麻。在本例中,一名年轻孕妇大量且长期吸食大麻后尿液中检测出大麻。她被警告说,如果她在怀孕期间继续使用大麻,她将被迫住院。她接受了为期 2-7 天的尿液检测。尿液中 11-去甲-9-羧基-Δ(9)-四氢大麻酚(THCCOOH)浓度通过液相色谱-质谱法测定,在令人惊讶的 12 周(84 天)内从 348 降至 3.9ng/ml。在此期间应用了几种用于检测新药物摄入的算法;大多数表明该妇女在第一次尿液检测后仍继续吸食大麻。该妇女否认第一次标本采集后有任何使用。回想起来,她的 THCCOOH 排泄情况支持了她的说法。用于检测新药物摄入的算法仅在偶尔吸食大麻的人群中得到验证。当涉及到严重后果时,我们建议在解释大量、长期吸食大麻者的尿液检测结果时要谨慎。

相似文献

1
Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use.短篇通讯:一名长期大量吸食大麻的孕妇体内 11-去甲-9-羧基-Δ(9)-四氢大麻醇的尿排泄。
J Anal Toxicol. 2009 Nov-Dec;33(9):610-4. doi: 10.1093/jat/33.9.610.
2
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.区分慢性、每日吸食大麻的患者中新的大麻使用与残留尿液中大麻素排泄。
Addiction. 2011 Mar;106(3):499-506. doi: 10.1111/j.1360-0443.2010.03228.x. Epub 2010 Dec 6.
3
Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.青少年和年轻成年大麻使用者在持续且经生物化学验证的戒断一个月期间的尿 11-去甲-9-羧基四氢大麻酚排泄。
J Psychopharmacol. 2020 Feb;34(2):197-210. doi: 10.1177/0269881119872206. Epub 2019 Sep 19.
4
Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.慢性大麻使用者队列中羧基四氢大麻酚的快速消除。
Int J Legal Med. 2016 Jan;130(1):147-52. doi: 10.1007/s00414-015-1241-z. Epub 2015 Aug 2.
5
Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.慢性大麻使用者尿液中Δ9-四氢大麻酚排泄时间延长,使其无法用作新药暴露的生物标志物。
Drug Alcohol Depend. 2009 Nov 1;105(1-2):24-32. doi: 10.1016/j.drugalcdep.2009.05.027. Epub 2009 Jul 23.
6
Elimination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol when normalized to urinary creatinine.将11-去甲-9-羧基-Δ⁹-四氢大麻酚消除量标准化至尿肌酐水平时。
Res Commun Mol Pathol Pharmacol. 2007;120-121(1-6):67-78.
7
Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections.通过尿液肌酐标准化的四氢大麻酚羧酸(THCCOOH)浓度以及样本采集之间的时间间隔来识别新的大麻使用情况。
J Anal Toxicol. 2009 May;33(4):185-9. doi: 10.1093/jat/33.4.185.
8
Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence.在持续监测的戒断期间大麻使用者中11-去甲-9-羧基-δ9-四氢大麻酚的尿液排泄情况
J Anal Toxicol. 2008 Oct;32(8):562-9. doi: 10.1093/jat/32.8.562.
9
Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.口服Δ⁹-四氢大麻酚后11-去甲-9-羧基-Δ⁹-四氢大麻酚的尿液药代动力学
J Anal Toxicol. 2004 Apr;28(3):160-7. doi: 10.1093/jat/28.3.160.
10
Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?偶尔吸烟者和频繁吸烟者尿液中大麻素的分布:频繁吸烟者尿样中 THC-葡糖苷酸是否是近期使用的标志物?
Clin Chem. 2014 Feb;60(2):361-72. doi: 10.1373/clinchem.2013.214106. Epub 2013 Nov 1.

引用本文的文献

1
Evidence on the effect of in-utero cannabis exposure in neonates.关于新生儿子宫内接触大麻影响的证据。
J Perinatol. 2025 Aug 13. doi: 10.1038/s41372-025-02383-1.
2
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions.特殊人群中的大麻二酚(CBD)和四氢大麻酚(THC):药代动力学与药物相互作用
Pharmaceutics. 2024 Apr 1;16(4):484. doi: 10.3390/pharmaceutics16040484.
3
Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding.大麻及其衍生物在孕期和哺乳期动物及人体中的药代动力学
Front Pharmacol. 2022 Jul 12;13:919630. doi: 10.3389/fphar.2022.919630. eCollection 2022.
4
Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.青少年和年轻成年大麻使用者在持续且经生物化学验证的戒断一个月期间的尿 11-去甲-9-羧基四氢大麻酚排泄。
J Psychopharmacol. 2020 Feb;34(2):197-210. doi: 10.1177/0269881119872206. Epub 2019 Sep 19.
5
Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being.早孕期同时使用烟草和大麻与产前免疫反应和心理社会健康的关系。
Neurotoxicol Teratol. 2019 May-Jun;73:42-48. doi: 10.1016/j.ntt.2019.03.002. Epub 2019 Mar 29.
6
Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.采用超高效液相色谱-四极杆飞行时间质谱法对尿液中的合成大麻素代谢物进行筛查、定量和确证。
Drug Test Anal. 2019 Jan;11(1):51-67. doi: 10.1002/dta.2464. Epub 2018 Sep 8.
7
Characteristics and quality of life of opioid-dependent pregnant women in Austria.奥地利阿片类药物依赖孕妇的特征与生活质量
Arch Womens Ment Health. 2014 Dec;17(6):529-39. doi: 10.1007/s00737-014-0443-6. Epub 2014 Jul 15.
8
Can physical exercise or food deprivation cause release of fat-stored cannabinoids?
Basic Clin Pharmacol Toxicol. 2014 Nov;115(5):467-71. doi: 10.1111/bcpt.12235. Epub 2014 Apr 22.